Times of extreme volatility in financial markets can be unnerving for all involved. However, times like these also present terrific opportunities for those that are willing to take a chance and buy something at a discount. One such stock that I think will come out of the crisis relatively unscathed is Johnson & Johnson (JNJ), as its mix of revenue is diversified enough that its earnings should remain mostly intact. With shares trading at a meaningful discount to pre-crisis levels, if you wanted to own J&J, the time is now.

J&J’s product mix and geographic reach rivals just about any other company on earth. The company has three main segments – Consumer, Pharmaceutical, and Medical Devices – and all three provide meaningful contributions to revenue and earnings. In addition, all three have immense product portfolios and are sold the world over, helping to insulate from weakness in one particular area of the globe, or one specific industry.

READ FULL ARTICLE HERE